# Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial

Study · id `cardio:ct-nct02577965` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02577965](<https://clinicaltrials.gov/study/NCT02577965>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02577965

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

## Technical summary

Registry record NCT02577965. Randomized; double masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2012-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 140 participants (enrolled count; ClinicalTrials.gov record NCT02577965, source copy `cardio:ctgov-nct02577965-2015-10-16`, retrieved 2026-10-26)
- Start date: 2011-03 (registry gives no type) (ClinicalTrials.gov record NCT02577965, source copy `cardio:ctgov-nct02577965-2015-10-16`, retrieved 2026-10-26)
- Primary completion: 2012-06 (actual) (ClinicalTrials.gov record NCT02577965, source copy `cardio:ctgov-nct02577965-2015-10-16`, retrieved 2026-10-26)
- Completion: 2014-09 (actual) (ClinicalTrials.gov record NCT02577965, source copy `cardio:ctgov-nct02577965-2015-10-16`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02577965-2015-10-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial
- Acronym: OCTAVIA
- Condition: Acute Myocardial Infarction
- Intervention (Procedure): Percutaneous Coronary Intervention
- Intervention (Device): XIENCE PRIME Everolimus Eluting Coronary Stent System
- Lead sponsor: A.O. Ospedale Papa Giovanni XXIII
- Lead sponsor class: OTHER
- Collaborator: Light Lab Imaging, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)

## Provenance

Content hash: 678c6b89a619a98337d07f8819cbd1e9260ea6a7c8a4025ab307f753df1a0fd1
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
